Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-10,000
Closed -$534K 476
2017
Q3
$534K Buy
+10,000
New +$502K 0.03% 270
2017
Q2
Sell
-162
Closed -$7K 327
2017
Q1
$7K Buy
+162
New +$7K ﹤0.01% 448
2016
Q4
Sell
-2,376
Closed -$100K 365
2016
Q3
$100K Buy
+2,376
New +$102K ﹤0.01% 427
2015
Q4
Sell
-15,000
Closed -$603K 446
2015
Q3
$603K Buy
15,000
+1,500
+11% +$70.7K 0.02% 391
2015
Q2
$663K Sell
13,500
-11,500
-46% -$552K 0.02% 386
2015
Q1
$1.16M Sell
25,000
-12,500
-33% -$574K 0.04% 291
2014
Q4
$1.69M Buy
37,500
+10,000
+36% +$436K 0.05% 263
2014
Q3
$1.14M Buy
27,500
+2,500
+10% +$106K 0.03% 337
2014
Q2
$1.02M Buy
25,000
+2,500
+11% +$98.2K 0.02% 316
2014
Q1
$866K Sell
22,500
-260
-1% -$10K 0.02% 308
2013
Q4
$872K Buy
+22,760
New +$839K 0.06% 156

Other funds holding ABT

GLG Partners's ABT Position: Q4 2017 in Review

GLG Partners sold out of Abbott (ABT) in Q4 2017, closing a stake of 10,000 shares — an estimated $534K sold.

GLG Partners first reported a position in ABT in Q4 2013 and held it in 11 quarters. The position peaked at $1.69M in Q4 2014. 1,753 funds tracked by Wall St. Rank hold ABT as of Q4 2017.

  • GLG Partners reported no remaining Abbott position as of Q4 2017 after selling out during the quarter.
  • GLG Partners sold 10,000 Abbott shares in Q4 2017, an estimated $534K.
  • GLG Partners first reported a position in Abbott in Q4 2013 and held it in 11 quarters.
  • GLG Partners's Abbott position peaked at $1.69M in Q4 2014.
  • 1,753 funds tracked by Wall St. Rank held Abbott as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.